NetScientific’s Glycotest to complete recent fundraising later this year
US-based Glycotest had initially hoped to have the funding round completed by the end of June
Company
EMV Capital
LON:NSCI
EMV Capital plc is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies. With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, the group invests in, manages, and strengthens early stage IP-rich companies.
424 stories · page 18 of 22
Archive
Proactive news round-up: Sound Energy, Europa Oil & Gas, Galileo Resources ...
A glance at some of the headlines on the Proactive newswire today...
Archive
Proactive news round-up: Tertiary Minerals, Vast Resources, Netscientific ...
A round-up of small cap stories on the London market today
Netscientific raises up to £9.8mln as portfolio companies approach maturity
A placing and subscription at 45p will raise £8.1mln, while a further £1.5mln can come from a private placing
Archive
Proactive news round-up: Metal Tiger , Europa Oil & Gas, Falcon Media...
A glance at the small cap stories on the Proactive newswire today...
Trakm8 shares jump on roadside assistance technology company telematics contract win
A look at some of the biggest London-listed risers and fallers today
Netscientific business Vortex Bio kicks off lung cancer proof of concept trial
These studies are designed to provide proof of principle that biomarkers used for tumour biopsises can be adapted for circulating tumour cells (CTCs).
Archive
Proactive end of days news wrap: LGO Energy, Anglo Pacific, Caspian Sunrise...
A glance at the stories on the Proactive newswire today
Fruitflow dietary supplement group Provexis gets a boost
A look at some of the biggest London-listed risers and fallers today
NetScientific portfolio company ProAxsis secures second licensing deal for its ProteaseTag technology
“This agreement, which strengthens the company's intellectual property portfolio, puts ProAxsis in a great position to launch further immunoassays and point of care tests”
Footsie up ahead of close; unrest at ITV hits shares
The bulls could not quite push the top-share index above 7,400. Tomorrow they'll have a harder job with ex-div stocks lopping about 14 points off the Footsie
NetScientific: ProAxsis to present ProteaseTag data at ATS conference
The American Thoracic Society (ATS) conference takes place in Washington DC, between May 19 and May 24.
Archive
Proactive news round-up: Avacta Group, Galantas Gold, Aminex …
A glance at some of the stories on the Proactive newswire today
Motif Bio gains as Rodman & Renshaw hikes target price
A look at the top risers and fallers in London on Monday
NetScientific’s portfolio company nets “strong return” from sale of OncoVerse stake
Wanda has offloaded its holding in digital health platform OncoVerse to BTG plc for an undisclosed sum
FTSE 100 closes over 2% higher as France vote cheers
The FTSE 100 closed 150 points, or 2.11% higher, as investors welcomed Macron's result in the first round of France's presidential election
Archive
Proactive news round-up: AFC Energy, Telit Communications, Brave Bison ...
A glance at some of the stories on the Proactive newswire today
NetScientific to focus on enhancing value of portfolio this year
The board will continue to evaluate new pipeline opportunities but the focus in 2017 will be on growing what it has already got